Corporate Profile
Web Site:
Founded:
2005
Registration country:
United States
Overview
Headquartered in Seattle, Theraclone Sciences is a discovery-stage biotech developing novel therapeutic antibodies for the treatment of infectious disease and inflammation. Our proprietary discovery platform allows us to comprehensively screen and identify the rare antibodies that select individuals produce to successfully ward off disease.
Investors
| Investor | Profile | Amount | Stage | Date | ||
|---|---|---|---|---|---|---|
| ARCH Venture Partners | Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup | Other venture | Mar 2010 | |||
| ARCH Venture Partners | Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup | USD | Series B | Sep 2011 | ||
| Accelerator Corp | ||||||
| Alexandria Real Estate Equities Inc | USD | Mar 2010 | ||||
| Alexandria Real Estate Equities Inc | USD | Series B | Sep 2011 | |||
| Amgen Inc | USD | Series B | Sep 2011 | |||
| Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | USD | Mar 2010 | |||
| Canaan Partners | Venture capital firm with a focus on early stage technology and healthcare companies | USD | Series B | Sep 2011 | ||
| Healthcare Ventures LLC | USD | Mar 2010 | ||||
| Healthcare Ventures LLC | USD | Series B | Sep 2011 | |||
| MPM Asset Management LLC | ||||||
| MPM Capital | USD | Mar 2010 | ||||
| MPM Capital | USD | Series B | Sep 2011 | |||
| Versant Ventures | USD | Mar 2010 |
Current employees
No current employees available
RECORD ID: 111315
